Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway

References

• Solberg IC, Vatn MH, Hoie O, Stray N, Sauar J, Jahnsen J, Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol 2007;5:1430–8.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–40.
   PubMed Web of Science ®Google Scholar
• Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory Bowel diseases. Gastroenterology 2011;140:1785–94.
   PubMed Web of Science ®Google Scholar
• Van AG, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010;4:7–27.
   PubMed Web of Science ®Google Scholar
• Thomas KJ, Nicholl JP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med 2001;9:2–11.
   PubMed Web of Science ®Google Scholar
• Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Complement Ther Med 2000;8:88–96.
   PubMed Web of Science ®Google Scholar
• Durber J, Otley A. Complementary and alternative medicine in inflammatory bowel disease: keeping an open mind. Expert Rev Clin Immunol 2005;1:277–92.
   PubMedGoogle Scholar
• Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B. Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006;6:19.
   PubMedGoogle Scholar
• Burgmann T, Rawsthorne P, Bernstein CN. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use? Am J Gastroenterol 2004;99:889–93.
   PubMedGoogle Scholar
• Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scand J Gastroenterol 2003;38:277–82.
   PubMed Web of Science ®Google Scholar
• Hilsden RJ, Verhoef MJ, Rasmussen H, Porcino A, Debruyn JC. Use of complementary and alternative medicine by patients with inflammatory bowel disease. Inflamm Bowel Dis 2011;17:655–62.
   PubMedGoogle Scholar
• Fonnebo V, Launso L. High use of complementary and alternative medicine inside and outside of the government-funded health care system in Norway. J Altern Complement Med 2009;15:1061–6.
   PubMed Web of Science ®Google Scholar
• NCCAM publication. What is CAM? 2012. Available at http://nccam.nih.gov/health/whatiscam/. Cited 17 April 2012.
   Google Scholar
• Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, Kristoffersen AE, Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med 2009;15:331–9.
   PubMed Web of Science ®Google Scholar
• Weidenhammer W, Lewith G, Falkenberg T, Fonnebo V, Johannessen H, Reiter B, EU FP7 Project 'CAMbrella' to Build European Research Network for Complementary and Alternative Medicine. Forsch Komplementmed 2011;18:69–76.
   PubMedGoogle Scholar
• Opheim R, Hoivik ML, Solberg IC, Moum B. Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). J Crohns Colitis 2012;6:345–53.
   PubMedGoogle Scholar
• Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19:5–36.
   PubMed Web of Science ®Google Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
   PubMed Web of Science ®Google Scholar
• Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998;43:29–32.
   PubMed Web of Science ®Google Scholar
• The Norwegian Health Directorate. Behøver jeg å ta kosttilskudd? 12 A.D. Available at http://helsenorge.no/Helseogsunnhet/Sider/Kosttilskudd.aspx. Cited 12 A.D. June 12.
   Google Scholar
• Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, Bouche O, Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey. Gastroenterol Clin Biol 2006;30:14–23.
   PubMed Web of Science ®Google Scholar
• Bertomoro P, Renna S, Cottone M, Riegler G, Bossa F, Giglio L, Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: An IG-IBD study. J Crohns Colitis 2010;4:291–300.
   PubMedGoogle Scholar
• Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002;8:174–9.
   PubMed Web of Science ®Google Scholar
• Lakatos PL, Czegledi Z, David G, Kispal Z, Kiss LS, Palatka K, Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. J Crohns Colitis 2010;4:283–90.
   PubMed Web of Science ®Google Scholar
• Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Lofberg R, Bohman L, An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1298–303.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Anthonisen IB, Steder-Neukamm U, Ludtke R, Spahn G, Michalsen A, Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005;11:287–95.
   PubMed Web of Science ®Google Scholar
• Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005;39:138–41.
   PubMed Web of Science ®Google Scholar
• Rawsthorne P, Clara I, Graff LA, Bernstein KI, Carr R, Walker JR, The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products. Gut 2012;61:521–7.
   PubMed Web of Science ®Google Scholar
• Schneider A, Streitberger K, Joos S. Acupuncture treatment in gastrointestinal diseases: a systematic review. World J Gastroenterol 2007;13:3417–24.
   PubMedGoogle Scholar
• Paterson C, Baarts C, Launso L, Verhoef MJ. Evaluating complex health interventions: a critical analysis of the ‘outcomes' concept. BMC Complement Altern Med 2009;9:18.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Anthonisen IB, Steder-Neukamm U, Luedtke R, Spahn G, Michalsen A, Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med 2007;15:30–7.
   PubMed Web of Science ®Google Scholar
• Johannson L, Solvoll K; Statens råd for ernæring og fysisk aktivitet. NORKOST II Nation-wide diet and householdbudget survey. 12 A.D. Available at http://helsedirektoratet.no/folkehelse/ernering/tall-og-undersokelser. Cited 12 A.D. June 4.
   Google Scholar
• WHO. World Health Organization. WHO Traditional Medicine Strategy 2002-2005. 2012. Available at http://www.who.int/medicines/publications/traditionalpolicy/en/index.html. Cited 30 April 2012.
   Google Scholar
• Boye B, Lundin KE, Jantschek G, Leganger S, Mokleby K, Tangen T, INSPIRE study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis 2011;17:1863–73.
   PubMed Web of Science ®Google Scholar
• Tippens K, Marsman K, Zwickey H. Is prayer CAM? J Altern Complement Med 2009;15:435–8.
   PubMed Web of Science ®Google Scholar
• Frass M, Strassl RP, Friehs H, Mullner M, Kundi M, Kaye AD. Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012;12:45–56.
   PubMedGoogle Scholar
• Hanssen B, Grimsgaard S, Launso L, Fonnebo V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care 2005;23:57–62.
   PubMed Web of Science ®Google Scholar
• Steinsbekk A, Rise MB, Johnsen R. Changes among male and female visitors to practitioners of complementary and alternative medicine in a large adult Norwegian population from 1997 to 2008 (The HUNT studies). BMC Complement Altern Med 2011;11:61.
   PubMedGoogle Scholar
• Steinsbekk A, Adams J, Sibbritt D, Johnsen R. Complementary and alternative medicine practitioner consultations among those who have or have had cancer in a Norwegian total population (Nord-Trondelag Health Study): prevalence, socio-demographics and health perceptions. Eur J Cancer Care (Engl) 2010;19:346–51.
   PubMedGoogle Scholar
• Verhoef MJ, Hilsden RJ, O'Beirne M. Complementary therapies and cancer care: an overview. Patient Educ Couns 1999;38:93–100.
   PubMedGoogle Scholar
• Goldstein MS, Brown ER, Ballard-Barbash R, Morgenstern H, Bastani R, Lee J, The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med 2005;2:557–65.
   PubMed Web of Science ®Google Scholar
• Hilsden RJ, Meddings JB, Verhoef MJ. Complementary and alternative medicine use by patients with inflammatory bowel disease: an internet survey. Can J Gastroenterol 1999;13:327–32.
   PubMed Web of Science ®Google Scholar
• Sirois FM. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services. Complement Ther Med 2008;16:73–80.
   PubMed Web of Science ®Google Scholar
• Li FX, Verhoef MJ, Best A, Otley A, Hilsden RJ. Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. Can J Gastroenterol 2005;19:567–73.
   PubMed Web of Science ®Google Scholar
• Weizman AV, Ahn E, Thanabalan R, Leung W, Croitoru K, Silverberg MS, Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:342–9.
   PubMed Web of Science ®Google Scholar
• Heuschkel R, Afzal N, Wuerth A, Zurakowski D, Leichtner A, Kemper K, Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002;97:382–8.
   PubMed Web of Science ®Google Scholar